1. Home
  2. ALTI vs AQST Comparison

ALTI vs AQST Comparison

Compare ALTI & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALTI
  • AQST
  • Stock Information
  • Founded
  • ALTI 2020
  • AQST 2004
  • Country
  • ALTI United States
  • AQST United States
  • Employees
  • ALTI N/A
  • AQST N/A
  • Industry
  • ALTI Investment Managers
  • AQST Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALTI Finance
  • AQST Health Care
  • Exchange
  • ALTI Nasdaq
  • AQST Nasdaq
  • Market Cap
  • ALTI 406.5M
  • AQST 272.9M
  • IPO Year
  • ALTI N/A
  • AQST 2018
  • Fundamental
  • Price
  • ALTI $4.13
  • AQST $3.31
  • Analyst Decision
  • ALTI
  • AQST Strong Buy
  • Analyst Count
  • ALTI 0
  • AQST 6
  • Target Price
  • ALTI N/A
  • AQST $10.67
  • AVG Volume (30 Days)
  • ALTI 271.0K
  • AQST 1.6M
  • Earning Date
  • ALTI 08-08-2025
  • AQST 08-05-2025
  • Dividend Yield
  • ALTI N/A
  • AQST N/A
  • EPS Growth
  • ALTI N/A
  • AQST N/A
  • EPS
  • ALTI N/A
  • AQST N/A
  • Revenue
  • ALTI $214,086,000.00
  • AQST $54,228,000.00
  • Revenue This Year
  • ALTI $24.86
  • AQST N/A
  • Revenue Next Year
  • ALTI $10.74
  • AQST $45.71
  • P/E Ratio
  • ALTI N/A
  • AQST N/A
  • Revenue Growth
  • ALTI N/A
  • AQST 5.29
  • 52 Week Low
  • ALTI $2.33
  • AQST $2.12
  • 52 Week High
  • ALTI $5.36
  • AQST $5.80
  • Technical
  • Relative Strength Index (RSI)
  • ALTI 71.65
  • AQST 54.11
  • Support Level
  • ALTI $3.94
  • AQST $3.13
  • Resistance Level
  • ALTI $4.24
  • AQST $3.46
  • Average True Range (ATR)
  • ALTI 0.24
  • AQST 0.24
  • MACD
  • ALTI 0.01
  • AQST -0.04
  • Stochastic Oscillator
  • ALTI 89.29
  • AQST 17.52

About ALTI AlTi Global Inc.

AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments namely: Wealth & Capital Solutions and International Real Estate segment includes providing holistic solutions for wealth management clients through comprehensive range of wealth management services, including investment management and advisory services. International Real Estate segment includes assist investors with real estate co-investments, structuring and selecting partners with a proven track record with risk adjusted return characteristics.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: